Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Other Operating Expenses (2018 - 2025)

Traws Pharma (TRAW) has disclosed Other Operating Expenses for 3 consecutive years, with -$889000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 8.35% year-over-year to -$889000.0; the TTM value through Dec 2025 reached -$3.8 million, down 103.38%, while the annual FY2025 figure was -$2.6 million, 102.27% down from the prior year.
  • Other Operating Expenses hit -$889000.0 in Q4 2025 for Traws Pharma, down from -$499000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $116.6 million in Q2 2024 and bottomed at -$2.6 million in Q1 2024.